PRODUCTS
`
`MARKETS
`
`CORE TECHNOLOGIES
`
`NEWS
`
`ABOUT US
`
`CONTACT
`
`April 10, 2006
`INVESTOR CONTACT:
`
`MEDIA CONTACT:
`
`News Room
`Resources
`
`Related Links
`
`News Releases
`
`ZOLL in the News
`
`Corporate Milestones
`
`Management Team
`
`News Releases Archives
`
`HOME
`
`CAREERS
`
`SITE MAP
`
`United States – English
`United States – English
`
`SEARCH
`
`A. Ernest Whiton
`Chief Financial Officer
`ZOLL Medical Corporation
`+1 (978) 421-9655
`
`Diane Egan
`ZOLL Medical Corporation
`+1 (978) 421-9637
`degan@zoll.com
`
`2012
`
`2011
`
`2010
`
`2009
`
`2008
`
`2007
`
`2006
`
`2005
`
`2004
`
`2003
`
`2002
`
`2001
`
`FOR IMMEDIATE RELEASE
`
`ZOLL Medical Completes Acquisition of Business of LifeCor, Inc.
`
`Monday, April 10, 2006—CHELMSFORD, MASS.—ZOLL Medical Corporation (NASDAQ: ZOLL), a
`manufacturer of resuscitation devices and related software solutions, today announced that it had
`completed the acquisition of the assets of Lifecor, Inc., a privately owned medical equipment company
`that designs, manufactures and markets a wearable external defibrillator system. ZOLL had
`announced on March 22, 2006 that it had exercised a previously granted option to acquire the assets.
`
`As a result of the transaction, ZOLL acquired Lifecor’s assets and business, assumed Lifecor’s
`outstanding debt of approximately $5.8 million (plus an additional $3.0 million owed to ZOLL), and
`also assumed certain stated liabilities of approximately $1.5 million. Additional consideration will be in
`the form of earn-out payments to Lifecor based upon future revenue growth of the acquired business
`over a five-year period.
`
`ZOLL will operate the Lifecor business through its ZOLL Lifecor subsidiary, based in Pittsburgh,
`Pennsylvania.
`
`The principal acquisition agreements between ZOLL and Lifecor were filed by ZOLL with the Securities
`and Exchange Commission on September 20, 2005 as exhibits to a current report on Form 8-K.
`About ZOLL Medical Corporation
`ZOLL Medical Corporation is committed to developing technologies that help advance the practice of
`resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation,
`ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay
`rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software
`that automates the documentation and management of both clinical and non-clinical information.
`
`ZOLL markets and sells its products in more than 140 countries. The Company has direct operations,
`distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the
`Middle East, Asia, and Australia. For more information, visit www.zoll.com or call
`+1 (978) 421-9655.
`
`Certain statements contained in this press release regarding matters that are not historical facts are
`“forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995).
`Because such statements are subject to risks and uncertainties, actual results may differ materially
`from those expressed or implied by such forward-looking statements. Factors that could cause actual
`results to differ materially from those expressed or implied by such forward-looking statements
`include, but are not limited to, ZOLL’s ability to compete; acceptance of its resuscitation products;
`changes in regulations affecting the healthcare industry; general economic conditions; and those other
`factors discussed in the section entitled “Risk Factors” in ZOLL’s Quarterly Report on Form 10-Q,
`which was filed with the SEC on February 10, 2006.
`
`© 2006 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL is a registered
`trademark of ZOLL Medical Corporation. All product names are the property of their respective owners.
`
`Philips Exhibit 2001
`Zoll Lifecor v. Philips
`IPR2013-00609
`
`Page 1 of 2
`
`

`

`
`
`© Copyright ZOLL Medical Corporation. All rights reserved. Site Map | Terms of Use
`
`Page 2 of 2
`
`